Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

AbbVie backs out of Shire deal

17 October 2014 Business

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits

Endo outbids QLT for Auxilium merger

10 October 2014 Business

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo

EMA finalises trial transparency rules

8 October 2014 Business

Researcher access reinstated, but company redaction rights may cause issues

Actavis boosts antibiotics with Durata buyout

8 October 2014 Business

$820 million deal gives Actavis control of newly-approved intravenous antibiotic

Becton Dickinson to buy CareFusion for $12bn

7 October 2014 Business

Medical devices merger continues consolidation trend

J&J to buy antiviral specialist Alios

1 October 2014 Business

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus

Dow’s $1bn price-fixing fine upheld

1 October 2014 Business

Firm loses its appeal against damages for fixing polyurethane prices

Lumara splits and sells to AMAG and Perrigo

30 September 2014 Business

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products

Mitsubishi to buy Japanese gases specialist

30 September 2014 Business

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry

India backs off drug pricing controls

25 September 2014 Business

Current price caps will stand, but rules on how new caps can be imposed are being tightened

Review says cheaper drug is safe for eye disease

24 September 2014 Business

Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar

Gilead licenses generic hepatitis C drug in India

23 September 2014 Business

Company aims to head off competition and grab a slice of royalties

Freeing a world of fixers

16 September 2014 Business

Company profile: Sugru mouldable silicone rubber lets you mend what’s broken and hack stuff better

Halliburton settles Deepwater Horizon claims

3 September 2014 Business

Company will pay $1.1bn for damage to property and commercial fishing

Novo Nordisk quits inflammation R&D and cuts jobs

3 September 2014 Business

Firm will return to primary focus on diabetes and obesity

Exelexis slashes workforce by 70%

2 September 2014 Business

Poor clinical trial performance pushes company into cost-cutting drive

DuPont settles pollution charges for $1.3m

28 August 2014 Business

Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010

Clinical collaborations drive cancer immunotherapy

27 August 2014 Business

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials

Illumina targets cancer diagnostics

22 August 2014 Business

Sequencing will improve tests and speed up clinical trials processes for big pharma partners

Sanofi snaps up inhaled insulin licence

12 August 2014 Business

Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza

Single shot antibiotic approved for skin infections

11 August 2014 Business

Third drug in three months approved under US antimicrobials incentive scheme

Tetraethyl lead bribery case ends with four executives convicted

5 August 2014 Business

Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia

AstraZeneca stocks respiratory and cancer pipelines

31 July 2014 Business

A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company

Bruker winds down underperforming instrument lines

30 July 2014 Business

Stand-alone gas chromatographs and certain mass spectrometry products to be sold off

Reckitt Benckiser to spin out US pharma arm

28 July 2014 Business

Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products